Still under revision!!!

But Adams came to China for Professor Yang's new therapy; otherwise, he wouldn't have traveled thousands of miles here to be hospitalized. He's contemplating how to use this new therapy.

For example, he considered collaborating with his friends to open a humanitarian aid channel in the United Kingdom to bring in this biological agent in advance. However, this requires approval from Professor Yang's laboratory, and he might not agree to this approach; he has stated that priority must be given to the volunteers participating in the Phase I clinical trial.

But the subjects for the Phase I clinical trial are all healthy people, and Adams is a patient, which means he doesn't meet the requirements. Moreover, the Phase I clinical trial is currently limited to China, leaving him no opportunity to sneak in.

Adams won't give up this opportunity; there's another way, which is expanding the Phase I clinical trial to the United Kingdom. As long as the biological agent can be introduced into the United Kingdom through the Phase I clinical trial, he has a solution.

Thinking it over, these are all backdoor routes; none are official channels. Adams said, "If I stay here until the Phase I clinical trial ends and then participate in the Phase II clinical trial, is that possible?" Adams decided to cling to this thread of hope because he has no other options and can only hold onto this glimmer of hope tightly.

"You can join the Phase II clinical trial in Germany; Germany is our Phase II clinical trial center in Europe. However, you need to pass their screening to get on the volunteer list. Currently, we have three Phase II clinical trial centers: one in our country and the other two in the United States and Germany. Our domestic trial only recruits Chinese people." Professor Yang Ping understands the mindset of all patients, but must adhere to procedures.

If we rashly violate procedures, creating any trouble could lead to a worldwide disaster, and he cannot do such a thing.

The effectiveness and safety of the K Virus Therapy are currently really good, and he knows this, but it's only been confirmed on a small scale and hasn't been tested through scientific clinical trials. Science cannot rely on subjective assumptions; it must withstand scrutiny.

None of Adams's suggestions were feasible; he didn't insist further, opting for a tactical retreat by settling in first and gradually working out a solution.

Even if he can't find a solution immediately, as Professor Yang said earlier, he can still go to Germany to participate in the Phase II clinical trial. But what he doesn't know is that the slots in Germany's Phase II clinical trial have long been filled; there's no way it will be his turn.

However, there's still a possibility, which is to increase the number of slots for the Phase II clinical trial. This is entirely possible, as the current slots for the three centers are insufficient anyway. Within the legal scope, increasing the slots as much as possible is not a bad idea, as it will benefit more patients and also expand the experimental data.

"The slots over there have also been filled." Song Zimo gently reminded him.

Yang Ping recalled the list Tang Shun had shown him not long ago; indeed, those slots have been filled. So what now?

Since everyone is so enthusiastic, Yang Ping can reluctantly increase the slots for the Phase II clinical trial, and can even conduct it earlier. This is permitted in drug clinical trials, wherein if a Phase I trial shows good drug safety and initial efficacy signs, a Phase II trial can be considered to be conducted concurrently. This design is called "seamless" or "combined trials," significantly shortening the development cycle.

Yang Ping plans to proceed in this manner now. He doesn't lack volunteers, as a large number of patients worldwide are willing to volunteer and are scrambling for spots. As for production capacity, Ruixing's mass production laboratory is ready to start operating at any time; if necessary, they can have their preparation laboratory begin work in advance.

Adams seems unwilling to give up; he's very persistent. He expressed that even if he can't use K Therapy, he's willing to stay in China and accept treatment from Professor Yang Ping. He has made up his mind; whether he can be cured or not, he'll continue treatment here relentlessly.

Actually, his thought is correct; as long as he stays at Sanbo Hospital and continues as Professor Yang's patient, Professor Yang will definitely do his utmost and won't abandon him.

---

The patient with the broken guide wire spent a few days in the ICU and his condition was very stable. He has been transferred out of the ICU, although the opening of the occluded cerebral blood vessel has missed the golden window, leaving some sequelae, with slight numbness and weakness in the right limbs.

The patient, surnamed Qi, is a retired old professor, and his son is also a professor, and even a key talent recruited under the Thousand Talents Plan at Nandu Institute of Technology.

Because he lives near the City People's Hospital, his condition was urgent at that time, and he was directly taken to the City People's Hospital for rescue.

Whether it's myocardial ischemia or cerebral ischemia, these vascular occlusion diseases invariably require the fastest possible opening of the blood vessels so that tissues can receive blood infusion as soon as possible. Otherwise, it can lead to infarction, ultimately causing life-threatening situations or leaving disabilities. Myocardial infarction can easily result in loss of life, while cerebral tissue infarction can leave severe disabilities.

As a family member of the patient, his son, Professor Qi, was very understanding; he didn't pursue any responsibility for the chief surgeon, Doctor Jiao, nor did he have any intention to file a lawsuit through legal channels.

However, he requested the City People's Hospital to conduct an institution-wide special discussion, and he wants to participate in the discussion and make a speech. Dean Chen agreed to his request, although even without this request from Professor Qi, Dean Chen would have held an institution-wide discussion focused on this case, addressing the issue without targeting individuals, so that everyone can learn from it, accumulate experience, draw a lesson from it, and prevent similar incidents from happening.

If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.